{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:04:23Z","timestamp":1795053863361,"version":"4.10.2"},"reference-count":196,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCA-ITN-EJD grant","award":["675527"],"award-info":[{"award-number":["675527"]}]},{"name":"a Miguel Servet grant from the Instituto de Salud Carlos III","award":["CP17\/00114"],"award-info":[{"award-number":["CP17\/00114"]}]},{"name":"Institute of Health Carlos III Spain, Catalan Society of Pneumology (SOCAP 2019)","award":["grants PI15\/00582 and PI18\/00960"],"award-info":[{"award-number":["grants PI15\/00582 and PI18\/00960"]}]},{"name":"DCVA consortium grant","award":["PHAEDRA-IMPACT"],"award-info":[{"award-number":["PHAEDRA-IMPACT"]}]},{"name":"Dutch Lung Foundation (Longfonds) grant","award":["5.2.17.198J0"],"award-info":[{"award-number":["5.2.17.198J0"]}]},{"name":"Leiden University Foundation grant","award":["W18378-2-32"],"award-info":[{"award-number":["W18378-2-32"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a rare, complex, and progressive disease that is characterized by the abnormal remodeling of the pulmonary arteries that leads to right ventricular failure and death. Although our understanding of the causes for abnormal vascular remodeling in PAH is limited, accumulating evidence indicates that endothelial cell (EC) dysfunction is one of the first triggers initiating this process. EC dysfunction leads to the activation of several cellular signalling pathways in the endothelium, resulting in the uncontrolled proliferation of ECs, pulmonary artery smooth muscle cells, and fibroblasts, and eventually leads to vascular remodelling and the occlusion of the pulmonary blood vessels. Other factors that are related to EC dysfunction in PAH are an increase in endothelial to mesenchymal transition, inflammation, apoptosis, and thrombus formation. In this review, we outline the latest advances on the role of EC dysfunction in PAH and other forms of pulmonary hypertension. We also elaborate on the molecular signals that orchestrate EC dysfunction in PAH. Understanding the role and mechanisms of EC dysfunction will unravel the therapeutic potential of targeting this process in PAH.<\/jats:p>","DOI":"10.3390\/biomedicines9010057","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T19:55:56Z","timestamp":1610308556000},"page":"57","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-6344","authenticated-orcid":false,"given":"Kondababu","family":"Kurakula","sequence":"first","affiliation":[{"name":"Department of Cell and Chemical Biology, Laboratory for CardioVascular Cell Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-7581","authenticated-orcid":false,"given":"Val\u00e9rie F. E. D.","family":"Smolders","sequence":"additional","affiliation":[{"name":"Department of Surgery, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Tura-Ceide","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Hospital Cl\u00ednic-Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain"},{"name":"Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institut (IDIBGI), 17190 Girona, Catalonia, Spain"},{"name":"Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-8359","authenticated-orcid":false,"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-5760","authenticated-orcid":false,"given":"Paul H. A.","family":"Quax","sequence":"additional","affiliation":[{"name":"Department of Surgery, Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-6746","authenticated-orcid":false,"given":"Marie-Jos\u00e9","family":"Goumans","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Laboratory for CardioVascular Cell Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2018.08.083","article-title":"Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018","volume":"272","author":"Dumitrescu","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"K4","DOI":"10.1093\/eurheartj\/suz211","article-title":"The revised definition of pulmonary hypertension: Exploring the impact on patient management","volume":"21","author":"Simonneau","year":"2019","journal-title":"Eur. Heart J. Suppl. J. Eur. Soc. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/16000617.0096-2015","article-title":"Pulmonary hypertension","volume":"25","author":"Groeneveldt","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am. J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial Dysfunction in Pulmonary Hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"ref_9","first-page":"183","article-title":"Endothelial dysfunction: Cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vph.2008.06.003","article-title":"Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension","volume":"49","author":"Humbert","year":"2008","journal-title":"Vasc. Pharmacol."},{"key":"ref_11","first-page":"437","article-title":"The endothelium and genetics in pulmonary arterial hypertension","volume":"137","author":"Nicod","year":"2007","journal-title":"Swiss Med. Wkly."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dummer, A., Rol, N., Szulcek, R., Kurakula, K., Pan, X., Visser, B.I., Bogaard, H.J., DeRuiter, M.C., Goumans, M.J., and Hierck, B.P. (2018). Endothelial dysfunction in pulmonary arterial hypertension: Loss of cilia length regulation upon cytokine stimulation. Pulm. Circ., 8.","DOI":"10.1177\/2045894018764629"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1165\/rcmb.2010-0317OC","article-title":"Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension","volume":"45","author":"Tu","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","article-title":"Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension","volume":"198","author":"Dai","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ranchoux, B., Harvey, L.D., Ayon, R.J., Babicheva, A., Bonnet, S., Chan, S.Y., Yuan, J.X.J., and Perez, V.J. (2018). Endothelial dysfunction in pulmonary arterial hypertension: An evolving landscape (2017 Grover Conference Series). Pulm. Circ., 8.","DOI":"10.1177\/2045893217752912"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00018-017-2510-4","article-title":"BMP type II receptor as a therapeutic target in pulmonary arterial hypertension","volume":"74","author":"Orriols","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200108023450502","article-title":"Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred","volume":"345","author":"Newman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1164\/rccm.201205-0886OC","article-title":"Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension","volume":"186","author":"Larkin","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1128\/MCB.15.7.3479","article-title":"Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs","volume":"15","author":"Liu","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"a031989","DOI":"10.1101\/cshperspect.a031989","article-title":"Bone Morphogenetic Proteins in Vascular Homeostasis and Disease","volume":"10","author":"Goumans","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115472","DOI":"10.1016\/j.bone.2020.115472","article-title":"Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors","volume":"138","author":"Williams","year":"2020","journal-title":"Bone"},{"key":"ref_25","first-page":"832","article-title":"Regulatory RNAs controlling vascular (dys)function by affecting TGF-\u00df family signalling","volume":"14","author":"Kurakula","year":"2015","journal-title":"EXCLI J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.RES.0000166926.54293.68","article-title":"Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension","volume":"96","author":"Yang","year":"2005","journal-title":"Circ. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000200180.01710.e6","article-title":"Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension","volume":"98","author":"Kutryk","year":"2006","journal-title":"Circ. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"L740","DOI":"10.1152\/ajplung.00284.2002","article-title":"Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells","volume":"285","author":"Zhang","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","author":"Haimel","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Frump, A., Prewitt, A., and de Caestecker, M.P. (2018). BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series). Pulm. Circ., 8.","DOI":"10.1177\/2045894018765840"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Soon, E., Crosby, A., Southwood, M., Yang, P., Tajsic, T., Toshner, M., Appleby, S., Shanahan, C.M., Bloch, K.D., and Pepke-Zaba, J. (2015). Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production: A gateway to pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/rccm.201408-1509OC"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2006-11-058594","article-title":"Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.RES.0000215809.47923.fd","article-title":"Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice","volume":"98","author":"Long","year":"2006","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","article-title":"Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor","volume":"105","author":"Atkinson","year":"2002","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","article-title":"Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway","volume":"104","author":"Brock","year":"2009","journal-title":"Circ. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Andruska, A., and Spiekerkoetter, E. (2018). Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092499"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Happ\u00e9, C., Kurakula, K., Sun, X.Q., da Silva Goncalves Bos, D., Rol, N., Guignabert, C., Tu, L., Schalij, I., Wiesmeijer, K.C., and Tura-Ceide, O. (2020). The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient. Cells, 9.","DOI":"10.3390\/cells9061422"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","author":"Hong","year":"2008","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1465-9921-12-84","article-title":"Physiologic and molecular consequences of endothelial Bmpr2 mutation","volume":"12","author":"Majka","year":"2011","journal-title":"Respir. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/2045-8932.78100","article-title":"Expression of Mutant BMPR-II in Pulmonary Endothelial Cells Promotes Apoptosis and a Release of Factors that Stimulate Proliferation of Pulmonary Arterial Smooth Muscle Cells","volume":"1","author":"Yang","year":"2011","journal-title":"Pulm. Circ."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201906-1141OC","article-title":"Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension","volume":"201","author":"Hodgson","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nm.3877","article-title":"Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1165\/rcmb.2013-0349OC","article-title":"Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA Repair in pulmonary arterial hypertension","volume":"50","author":"Li","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201408-1528OC","article-title":"RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension","volume":"192","author":"Rhodes","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvy186","article-title":"Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension","volume":"115","author":"Rol","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"L187","DOI":"10.1152\/ajplung.00303.2015","article-title":"Raf\/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells","volume":"310","author":"Awad","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/CIRCULATIONAHA.119.040629","article-title":"Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation","volume":"140","author":"Tian","year":"2019","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000237166","article-title":"Pulmonary hypertension in rats. 2. Role of interleukin-6","volume":"108","author":"Miyata","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1038\/ncomms14079","article-title":"TNF\u03b1 drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","author":"Hurst","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Perros","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cyto.2015.06.018","article-title":"Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage","volume":"76","author":"Jasiewicz","year":"2015","journal-title":"Cytokine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1465-9921-15-47","article-title":"Inflammatory cytokines in pulmonary hypertension","volume":"15","author":"Groth","year":"2014","journal-title":"Respir. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10456-020-09741-x","article-title":"Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells","volume":"23","author":"Szulcek","year":"2020","journal-title":"Angiogenesis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0008-6363(99)00230-8","article-title":"Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension","volume":"44","author":"Cacoub","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: Natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0012-3692(15)51873-4","article-title":"Thrombotic arteriopathy and anticoagulation in pulmonary hypertension","volume":"130","author":"Johnson","year":"2006","journal-title":"Chest"},{"key":"ref_58","first-page":"376","article-title":"Coagulation and anticoagulation in pulmonary arterial hypertension","volume":"11","author":"Berger","year":"2009","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1378\/chest.128.4.2355","article-title":"Von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension","volume":"128","author":"Kawut","year":"2005","journal-title":"Chest"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.0000139859.68513.FC","article-title":"Soluble CD40 ligand in pulmonary arterial hypertension: Possible pathogenic role of the interaction between platelets and endothelial cells","volume":"110","author":"Otterdal","year":"2004","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3324\/haematol.2018.203026","article-title":"LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis","volume":"105","author":"Kroone","year":"2020","journal-title":"Haematologica"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3324\/haematol.2017.183087","article-title":"Structural and cellular mechanisms of peptidyl-prolyl isomerase Pin1-mediated enhancement of Tissue Factor gene expression, protein half-life, and pro-coagulant activity","volume":"103","author":"Kurakula","year":"2018","journal-title":"Haematologica"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"L583","DOI":"10.1152\/ajplung.00321.2006","article-title":"Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension","volume":"293","author":"White","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.200706-840OC","article-title":"Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension","volume":"177","author":"Bakouboula","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/j.thromres.2010.08.020","article-title":"Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension","volume":"126","author":"Tournier","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/ajrccm.150.4.7921465","article-title":"Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension","volume":"150","author":"Huber","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/2045893217701438","article-title":"The cancer theory of pulmonary arterial hypertension","volume":"7","author":"Boucherat","year":"2017","journal-title":"Pulm. Circ."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmolb.2018.00120","article-title":"Metabolic Alterations in Cardiopulmonary Vascular Dysfunction","volume":"5","author":"Smolders","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/CIRCULATIONAHA.114.006980","article-title":"Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension","volume":"131","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension","volume":"116","author":"Cao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Michelakis, E.D., Gurtu, V., Webster, L., Barnes, G., Watson, G., Howard, L., Cupitt, J., Paterson, I., Thompson, R.B., and Chow, K. (2017). Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aao4583"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Peng, J., Lu, C., Hsin, M., Mura, M., Wu, L., Chu, L., Zamel, R., Machuca, T., and Waddell, T. (2014). Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088727"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/685024","article-title":"Main pulmonary arterial wall shear stress correlates with invasive hemodynamics and stiffness in pulmonary hypertension","volume":"6","author":"Kheyfets","year":"2016","journal-title":"Pulm. Circ."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"H405","DOI":"10.1152\/ajpheart.00144.2014","article-title":"Diverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype","volume":"307","author":"Allen","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1183\/09059180.00003309","article-title":"Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease","volume":"18","author":"Gatzoulis","year":"2009","journal-title":"Eur. Respir. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/cvr\/cvw070","article-title":"Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension","volume":"111","author":"Abe","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"van der Feen, D.E., Bossers, G.P.L., Hagdorn, Q.A.J., Moonen, J.R., Kurakula, K., Szulcek, R., Chappell, J., Vallania, F., Donato, M., and Kok, K. (2020). Cellular senescence impairs the reversibility of pulmonary arterial hypertension. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.aaw4974"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"753210","DOI":"10.1155\/2015\/753210","article-title":"Novel Model of Pulmonary Artery Banding Leading to Right Heart Failure in Rats","volume":"2015","author":"Hirata","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201506-1231OC","article-title":"Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage","volume":"193","author":"Szulcek","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13239-012-0115-5","article-title":"High Pulsatility Flow Induces Acute Endothelial Inflammation through Overpolarizing Cells to Activate NF-\u03baB","volume":"4","author":"Li","year":"2013","journal-title":"Cardiovasc. Eng. Technol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: Regulation and function","volume":"33","author":"Sessa","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI117557","article-title":"Nitric oxide mediates angiogenesis In Vivo and endothelial cell growth and migration In Vitro promoted by substance P","volume":"94","author":"Ziche","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.RES.82.9.1007","article-title":"Role of nitric oxide in the angiogenic response In Vitro to basic fibroblast growth factor","volume":"82","author":"Babaei","year":"1998","journal-title":"Circ. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary Hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCGENETICS.111.961888","article-title":"Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension","volume":"5","author":"Austin","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Quinlan, T.R., Li, D., Laubach, V.E., Shesely, E.G., Zhou, N., and Johns, R.A. (2000). eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol.","DOI":"10.1152\/ajplung.2000.279.4.L641"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM199007053230106","article-title":"Regulatory Functions of the Vascular Endothelium","volume":"323","author":"Epstein","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9629(15)40831-6","article-title":"Endothelial Dysfunction in the Pulmonary Vascular Bed","volume":"320","author":"Chen","year":"2000","journal-title":"Am. J. Med. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of Pulmonary Arterial Hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_90","first-page":"382","article-title":"Role of prostacyclin in pulmonary hypertension","volume":"2014","author":"Mitchell","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Tuder, R.M., Cool, C.D., Geraci, M.W., Wang, J., Abman, S.H., Wright, L., Badesch, D., and Voelkel, N.F. (1999). Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/ajrccm.159.6.9804054"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1172\/JCI5911","article-title":"Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension","volume":"103","author":"Geraci","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_93","first-page":"62","article-title":"The role of endothelin-1 in pulmonary arterial hypertension","volume":"2014","author":"Chester","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.phrs.2011.03.003","article-title":"The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension","volume":"63","author":"Shao","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.HYP.30.5.1198","article-title":"Endothelin-1 as an autocrine\/paracrine apoptosis survival factor for endothelial cells","volume":"30","author":"Shichiri","year":"1997","journal-title":"Hypertension"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1152\/jappl.1994.77.3.1451","article-title":"Enhanced Endothelin-1 and Endothelin Receptor Gene-Expression in Chronic Hypoxia","volume":"77","author":"Li","year":"1994","journal-title":"J. Appl. Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"L304","DOI":"10.1152\/ajplung.1999.276.2.L304","article-title":"Endothelin-1 is elevated in monocrotaline pulmonary hypertension","volume":"276","author":"Frasch","year":"1999","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm.165.3.2104059","article-title":"ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells","volume":"165","author":"Davie","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Manes","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.953","article-title":"Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis","volume":"195","author":"Tuder","year":"2001","journal-title":"J. Pathol."},{"key":"ref_102","first-page":"00037","article-title":"Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation","volume":"5","author":"Bouzina","year":"2019","journal-title":"ERJ Open Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dvdy.24589","article-title":"Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry","volume":"247","year":"2018","journal-title":"Dev. Dyn."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.semcancer.2012.04.004","article-title":"Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype","volume":"22","author":"Medici","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","article-title":"Endothelial-to-mesenchymal transition in pulmonary hypertension","volume":"131","author":"Ranchoux","year":"2015","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension","volume":"185","author":"Good","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_107","first-page":"L256","article-title":"Endothelial HIF-2\u03b1 Contributes to Severe Pulmonary Hypertension by Inducing Endothelial-to-Mesenchymal Transition","volume":"314","author":"Tang","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tcm.2009.01.001","article-title":"Transforming growth factor beta-induced endothelial-to-mesenchymal transition: A switch to cardiac fibrosis?","volume":"18","author":"Goumans","year":"2008","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Ursoli Ferreira, F., Eduardo Botelho Souza, L., Hassibe Thom\u00e9, C., Tomazini Pinto, M., Origassa, C., Salustiano, S., Marcel Fa\u00e7a, V., Olsen C\u00e2mara, N., Kashima, S., and Tadeu Covas, D. (2019). Endothelial Cells Tissue-Specific Origins Affects Their Responsiveness to TGF-\u03b22 during Endothelial-to-Mesenchymal Transition. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030458"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1165\/rcmb.2016-0323OC","article-title":"Twist1 in Hypoxia-induced Pulmonary Hypertension through Transforming Growth Factor-\u03b2\u2013Smad Signaling","volume":"58","author":"Mammoto","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.115.020617","article-title":"In pulmonary arterial hypertension, reduced bmpr2 promotes endothelial-to-Mesenchymal transition via hmga1 and its target slug","volume":"133","author":"Hopper","year":"2016","journal-title":"Circulation"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Zhang, H., Liu, Y., Yan, L., Du, W., Zhang, X., Zhang, M., Chen, H., Zhang, Y., Zhou, J., and Sun, H. (2018). Bone morphogenetic protein-7 inhibits endothelial-mesenchymal transition in pulmonary artery endothelial cell under hypoxia. J. Cell. Physiol.","DOI":"10.1002\/jcp.26195"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Hiepen, C., Jatzlau, J., Hildebrandt, S., Kampfrath, B., Goktas, M., Murgai, A., Cuellar Camacho, J.L., Haag, R., Ruppert, C., and Sengle, G. (2019). BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGF\u03b2 responses and altered cell mechanics. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000557"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Rol, N., Kurakula, K.B., Happ\u00e9, C., Bogaard, H.J., and Goumans, M.J. (2018). TGF-\u03b2 and BMPR2 Signaling in PAH: Two Black Sheep in One Family. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092585"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3892\/mmr.2016.5752","article-title":"Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension","volume":"14","author":"Lei","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/rccm.201710-2079OC","article-title":"Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2\u03b1 Inhibitor","volume":"198","author":"Dai","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_117","first-page":"270","article-title":"Hypoxia induces endothelial-mesenchymal transition in pulmonary vascular remodeling","volume":"42","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"114827","DOI":"10.1016\/j.taap.2019.114827","article-title":"miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1","volume":"386","author":"Zhao","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","article-title":"Relevant issues in the pathology and pathobiology of pulmonary hypertension","volume":"62","author":"Tuder","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Kasahara","year":"2001","journal-title":"FASEB J."},{"key":"ref_121","first-page":"1178","article-title":"Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells","volume":"19","author":"Sakao","year":"2005","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cmet.2015.03.010","article-title":"BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension","volume":"21","author":"Diebold","year":"2015","journal-title":"Cell Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.113.03037","article-title":"Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA\/programmed cell death 4\/caspase-3 axis","volume":"64","author":"White","year":"2014","journal-title":"Hypertension"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1183\/13993003.00773-2015","article-title":"Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension","volume":"48","author":"Dabral","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.118.313374","article-title":"Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes","volume":"124","author":"Miyagawa","year":"2019","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"52995","DOI":"10.18632\/oncotarget.18031","article-title":"Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension","volume":"8","author":"Hautefort","year":"2017","journal-title":"Oncotarget"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/679700","article-title":"Emerging Roles for Histone Deacetylases in Pulmonary Hypertension and Right Ventricular Remodeling (2013 Grover Conference series)","volume":"5","author":"Cavasin","year":"2015","journal-title":"Pulm. Circ."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone Deacetylation Inhibition in Pulmonary Hypertension: Therapeutic of Valproic Acid and SuPotentialberoylanilide Hydroxamic Acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: The histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"774.4","DOI":"10.1096\/fasebj.30.1_supplement.774.4","article-title":"HDAC6-HSP90 interplay in pulmonary arterial hypertension","volume":"30","author":"Chabot","year":"2016","journal-title":"FASEB J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41598-017-04874-4","article-title":"HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension","volume":"7","author":"Boucherat","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.111.258426","article-title":"Selective class i histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism","volume":"110","author":"Cavasin","year":"2012","journal-title":"Circ. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4049\/jimmunol.1100479","article-title":"Emergence of Fibroblasts with a Proinflammatory Epigenetically Altered Phenotype in Severe Hypoxic Pulmonary Hypertension","volume":"187","author":"Li","year":"2011","journal-title":"J. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/CIRCULATIONAHA.114.013339","article-title":"Restoration of Impaired Endothelial MEF2 Function Rescues Pulmonary Arterial Hypertension","volume":"131","author":"Kim","year":"2015","journal-title":"Circulation"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1164\/rccm.201812-2275OC","article-title":"Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension","volume":"200","author":"Feen","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1189\/jlb.2RI0616-250R","article-title":"Bromodomain 4: A cellular Swiss army knife","volume":"100","author":"Devaiah","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.115.307004","article-title":"Bromodomain-Containing Protein 4","volume":"117","author":"Meloche","year":"2015","journal-title":"Circ. Res."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, A.I., Yotti, R., Gonz\u00e1lez-Mansilla, A., Mombiela, T., Guti\u00e9rrez-Ibanes, E., P\u00e9rez Del Villar, C., Navas-Tejedor, P., Chazo, C., Mart\u00ednez-Legazpi, P., and Fern\u00e1ndez-Avil\u00e9s, F. (2019). The Biological Bases of Group 2 Pulmonary Hypertension. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235884"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.RES.69.4.1088","article-title":"Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure","volume":"69","author":"Ontkean","year":"1991","journal-title":"Circ. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Meoli, D.F., Su, Y.R., Brittain, E.L., Robbins, I.M., Hemnes, A.R., and Monahan, K. (2018). The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension. Pulm. Circ., 8.","DOI":"10.1177\/2045893217745019"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Duarte, J.D., Kansal, M., Desai, A.A., Riden, K., Arwood, M.J., Yacob, A.A., Stamos, T.D., Cavallari, L.H., Zamanian, R.T., and Shah, S.J. (2018). Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients. Pulm. Circ., 8.","DOI":"10.1177\/2045894018773049"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1801897","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Tedford","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Szucs, B., Szucs, C., Petrekanits, M., and Varga, J.T. (2019). Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184329"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1164\/ajrccm.164.4.2101023","article-title":"Reduced Expression of Endothelial Nitric Oxide Synthase in Pulmonary Arteries of Smokers","volume":"164","author":"Peinado","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Nana-Sinkam, S.P., Jong, D.L., Sotto-Santiago, S., Stearman, R.S., Keith, R.L., Choudhury, Q., Cool, C., Parr, J., Moore, M.D., and Bull, T.M. (2007). Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/rccm.200605-724OC"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Santos, S., Peinado, V.I., Ram\u00edrez, J., Morales-Blanhir, J., Bastos, R., Roca, J., Rodriguez-Roisin, R., and Barber\u00e0, J.A. (2003). Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/rccm.200210-1233OC"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Carratu, P., Scoditti, C., Maniscalco, M., Seccia, T., Di Gioia, G., Gadaleta, F., Cardone, R., Dragonieri, S., Pierucci, P., and Spanevello, A. (2008). Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension. BMC Pulm. Med., 8.","DOI":"10.1186\/1471-2466-8-20"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/HYPERTENSIONAHA.117.08824","article-title":"Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension","volume":"71","author":"Xiong","year":"2018","journal-title":"Hypertension"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12931-015-0284-5","article-title":"Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema","volume":"16","author":"Reimann","year":"2015","journal-title":"Respir. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijcard.2018.08.043","article-title":"Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018","volume":"272","author":"Olschewski","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"160112","DOI":"10.1183\/16000617.0112-2016","article-title":"The pathophysiology of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Simonneau","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/ATVBAHA.114.304404","article-title":"Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension","volume":"34","author":"Yaoita","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09059180.00007309","article-title":"Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Pathophysiology","volume":"19","author":"Humbert","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1465-9921-12-109","article-title":"Endothelial-like cells in chronic thromboembolic pulmonary hypertension: Crosstalk with myofibroblast-like cells","volume":"12","author":"Sakao","year":"2011","journal-title":"Respir. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2016.08.012","article-title":"Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension","volume":"36","author":"Mercier","year":"2017","journal-title":"J. Heart Lung Transpl."},{"key":"ref_158","first-page":"PA3606","article-title":"Endothelial dysfunction in patients with chronic thromboembolic pulmonary hypertension (CTEPH)","volume":"48","author":"Piccari","year":"2016","journal-title":"Eur. Respir. Soc."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Naito, A., Sakao, S., Lang, I.M., Voelkel, N.F., Jujo, T., Ishida, K., Sugiura, T., Matsumiya, G., Yoshino, I., and Tanabe, N. (2018). Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor. BMC Pulm. Med., 18.","DOI":"10.1186\/s12890-018-0769-3"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1183\/09031936.00009914","article-title":"Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension","volume":"46","author":"Quarck","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.healun.2019.06.010","article-title":"ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension","volume":"38","author":"Mercier","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1165\/rcmb.2019-0409LE","article-title":"Decreased Glycolysis as Metabolic Fingerprint of Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension","volume":"63","author":"Smolders","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_163","first-page":"2210","article-title":"Role of FoxO1 and apoptosis in pulmonary vascular remolding in a rat model of chronic thromboembolic pulmonary hypertension","volume":"7","author":"Deng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1801805","DOI":"10.1183\/13993003.01805-2018","article-title":"The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension","volume":"53","author":"Newnham","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Zabini, D., Nagaraj, C., Stacher, E., Lang, I.M., Nierlich, P., Klepetko, W., Heinemann, A., Olschewski, H., B\u00e1lint, Z., and Olschewski, A. (2012). Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043793"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s40265-013-0149-5","article-title":"Riociguat: First global approval","volume":"73","author":"Conole","year":"2013","journal-title":"Drugs"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccl.2016.04.001","article-title":"WHO Group I Pulmonary Hypertension: Epidemiology and Pathophysiology","volume":"34","author":"Prins","year":"2016","journal-title":"Cardiol. Clin."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2018.08.082","article-title":"Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018","volume":"272S","author":"Hoeper","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Lan, N.S.H., Massam, B.D., Kulkarni, S.S., and Lang, C.C. (2018). Pulmonary Arterial Hypertension: Pathophysiology and Treatment. Diseases, 6.","DOI":"10.3390\/diseases6020038"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/thoraxjnl-2015-207170","article-title":"The molecular targets of approved treatments for pulmonary arterial hypertension","volume":"71","author":"Humbert","year":"2016","journal-title":"Thorax"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"17","DOI":"10.29245\/2572-9411\/2016\/2.1025","article-title":"Apoptosis-based therapy to treat pulmonary arterial hypertension","volume":"1","author":"Suzuki","year":"2016","journal-title":"J. Rare Dis. Res. Treat."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e000520","DOI":"10.1161\/JAHA.113.000520","article-title":"Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing","volume":"3","author":"Ibrahim","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1165\/rcmb.2011-0331OC","article-title":"Bortezomib alleviates experimental pulmonary arterial hypertension","volume":"47","author":"Kim","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11886-017-0846-x","article-title":"Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions","volume":"19","author":"Jain","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1164\/rccm.201510-1955OC","article-title":"A Selective Transforming Growth Factor-\u03b2 Ligand Trap Attenuates Pulmonary Hypertension","volume":"194","author":"Yung","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yexcr.2015.06.021","article-title":"Kallistatin inhibits TGF-\u03b2-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression","volume":"337","author":"Guo","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1701214","DOI":"10.1183\/13993003.01214-2017","article-title":"The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension","volume":"51","author":"Marsh","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1702403","DOI":"10.1183\/13993003.02403-2017","article-title":"How does inflammation contribute to pulmonary hypertension?","volume":"51","author":"Kumar","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.stem.2016.08.019","article-title":"Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers","volume":"20","author":"Gu","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCRESAHA.118.313356","article-title":"Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension","volume":"124","author":"Tu","year":"2019","journal-title":"Circ. Res."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Yung, L.M., Yang, P., Joshi, S., Augur, Z.M., Kim, S.S.J., Bocobo, G.A., Dinter, T., Troncone, L., Chen, P.S., and McNeil, M.E. (2020). ACTRIIA-Fc rebalances activin\/GDF versus BMP signaling in pulmonary hypertension. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.aaz5660"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Sanada, T.J., Sun, X.-Q., Happ\u00e9, C., Guignabert, C., Tu, L., Schalij, I., Bogaard, H.-J., Goumans, M.-J., and Kurakula, K. (2021). AlteredTGF\u03b2\/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention. Cells, 10.","DOI":"10.3390\/cells10010084"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/rccm.201411-2061LE","article-title":"Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension","volume":"192","author":"Spiekerkoetter","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"56","DOI":"10.21037\/sci.2017.05.11","article-title":"Rescuing BMPR2-driven endothelial dysfunction in PAH: A novel treatment strategy for the future?","volume":"4","author":"Quarck","year":"2017","journal-title":"Stem Cell Investig."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1802400","DOI":"10.1183\/13993003.02400-2018","article-title":"6-mercaptopurine, an agonist of Nur77, reduces progression of pulmonary hypertension by enhancing BMP signalling","volume":"54","author":"Kurakula","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Botros, L., Szulcek, R., Jansen, S.M., Kurakula, K., Goumans, M.T., van Kuilenburg, A.B.P., Vonk Noordegraaf, A., de Man, F.S., Aman, J., and Bogaard, H.J. (2020). The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/rccm.202003-0473LE"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Le Ribeuz, H., Dumont, F., Ruellou, G., Lambert, M., Balliau, T., Quatredeniers, M., Girerd, B., Cohen-Kaminsky, S., Mercier, O., and Yen-Nicola\u00ff, S. (2020). Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197400"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1165\/rcmb.2018-0165OC","article-title":"Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the EndMT","volume":"62","author":"Huang","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13287-017-0669-0","article-title":"Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension","volume":"8","author":"Felix","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00395-016-0573-2","article-title":"Mesenchymal stem cells attenuate inflammatory processes in the heart and lung via inhibition of TNF signaling","volume":"111","author":"Martire","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Macias, D., Moore, S., Crosby, A., Southwood, M., Du, X., Tan, H., Xie, S., Vassallo, A., Wood, A.J., and Wallace, E.M. (2020). Targeting HIF2\u03b1-ARNT hetero-dimerisation as a novel therapeutic strategy for Pulmonary Arterial Hypertension. Eur. Respir. J.","DOI":"10.1183\/13993003.02061-2019"},{"key":"ref_194","first-page":"541900378","article-title":"Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension","volume":"54","author":"Hu","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201007-1106OC","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fphar.2018.00241","article-title":"Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/1\/57\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:09:00Z","timestamp":1760159340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/1\/57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":196,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["biomedicines9010057"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9010057","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]}}}